Cardio Care Live

CME Presentations

PCSK9 Inhibitors and CV Risk Reduction

  • CME
    1.0

    The Emerging Role of PCSK9 Inhibitors and CV Risk Reduction

    Speakers:Michael J. Blaha, MD, MPH, Director of Clinical Research, Ciccarone Center for the Prevention of Heart Disease; Assistant Professor of Medicine
    Michael Miller, MD, FACC, FAHA, Professor of Cardiovascular Medicine, Epidemiology & Public Health

    Duration: 60 minutes

    Presented on: April 11, 2017

  • CME
    1.0

    CVD and PCSK9 Inhibitors: Analyzing the Outcome Studies and Understanding Their Implications

    Speakers:Marc S. Sabatine, MD, MPH, Lewis Dexter, MD Distinguished Chair in Cardiovascular Medicine

    Duration: 60 minutes

    Presented on: May 23, 2017

Cardiovascular Disease, Diabetes, and Diabetes Treatments

  • CME
    1.0

    Diabetes and Cardiovascular Disease: What are the Issues?

    Speakers:Donald E. Cutlip, MD, Section Chief, Interventional Cardiology
    Richard Beaser, MD, Senior Physician, Medical Director, Professional Education
    Vivian A. Fonseca, MD, FRCP, Professor of Medicine and Pharmacology; Chief, Section of Endocrinology

    Duration: 60 minutes

    Presented on: March 1, 2017

  • CME
    1.0

    Cardiovascular Disease and Diabetes Medications: Analyzing the Outcome Studies and Understanding their Implications

    Speakers:Donald E. Cutlip, MD, Section Chief, Interventional Cardiology
    Richard Beaser, MD, Senior Physician, Medical Director, Professional Education
    Robert E. Heinig, MD, Director, Vascular Disease Prevention Program
    Vivian A. Fonseca, MD, FRCP, Professor of Medicine and Pharmacology; Chief, Section of Endocrinology

    Duration: 60 minutes

    Presented on: March 1, 2017

  • CME
    1.0

    Cardiovascular Disease and Diabetes Medications: Applying Trial Outcomes to Clinical Practice

    Speakers:Michael Rocco, MD, Medical Director of Stress Testing and Cardiac Rehabilitation
    Richard Beaser, MD, Senior Physician, Medical Director, Professional Education
    Stephen A. Brunton, MD, FAAFP, Executive Vice President
    Om P. Ganda, MD, Medical Director of the Lipid Clinic, Chair of the Clinical Oversight Committee

    Duration: 60 minutes

    Presented on: March 29, 2017

Heart Failure

  • CME
    0.5

    Heart Failure Snapshot

    Speakers:Akshay Suvas Desai, MD, MPH, Associate Professor of Medicine
    James L. Januzzi, Jr., MD, FACC, FESC, Professor of Medicine

    Duration: 30 minutes

    Presented on: September 27, 2016

  • CME
    1.0

    State of the Art Pharmacotherapy for Heart Failure with Reduced Ejection Fraction

    Speakers:Akshay Suvas Desai, MD, MPH, Associate Professor of Medicine
    James L. Januzzi, Jr., MD, FACC, FESC, Professor of Medicine

    Duration: 60 minutes

    Presented on: September 27, 2016

  • CME
    0.5

    Game Changing Devices for Heart Failure: Electricity & Catheter-based Therapies

    Speakers:Jagmeet Singh, MD, DPhil, FHRS, Professor of Medicine

    Duration: 30 minutes

    Presented on: September 27, 2016

  • CME
    1.0

    Heart Failure Management Today and Tomorrow: A Roundtable Discussion

    Speakers:Akshay Suvas Desai, MD, MPH, Associate Professor of Medicine
    Jagmeet Singh, MD, DPhil, FHRS, Professor of Medicine
    James L. Januzzi, Jr., MD, FACC, FESC, Professor of Medicine

    Duration: 60 minutes

    Presented on: November 1, 2016